Lipella Pharmaceuticals Inc. Stock
Stocks
LIPO
US53630L2097
Biotechnology & Medical Research
OTC Markets Traded|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0327 USD | -49.38% |
|
0.00% | -81.83% |
| Market Cap | 832K 731K 681K 625K 1.17M 79.76M 1.19M 8.09M 3.16M 39.39M 3.12M 3.06M 136M | P/E 2023 |
-1.32x | P/E 2024 | -0.64x |
|---|---|---|---|---|---|
| Enterprise Value | -1.31M -1.15M -1.07M -981K -1.84M -125M -1.87M -12.7M -4.96M -61.82M -4.9M -4.8M -214M | EV / Sales 2023 |
6.14x | EV / Sales 2024 | 2.89x |
| Free-Float |
93.69% | Yield 2023 * |
-
| Yield 2024 | - |
| 25-02-11 | Top Midday Gainers | MT |
| 24-04-09 | Maxim Initiates Lipella Pharmaceuticals at Buy Rating With $2 Price Target | MT |
| 1 day | -49.38% | ||
| Current month | -71.49% | ||
| 1 month | -63.67% | ||
| 3 months | +6.51% | ||
| 6 months | -81.53% | ||
| Current year | -81.83% |
| 1 month | 0.03 |  | 0.13 |
| Current year | 0.02 | | 0.32 |
| 1 year | 0.02 | | 0.78 |
| 3 years | 0.02 | | 21.68 |
| 5 years | 0.02 | | 61.76 |
| 10 years | 0.02 | | 61.76 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jonathan Kaufman
CEO | Chief Executive Officer | 60 | 2004-12-31 |
Douglas Johnston
DFI | Director of Finance/CFO | 42 | 2021-09-30 |
Janet Okonski
CTO | Chief Tech/Sci/R&D Officer | - | 2021-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Jonathan Kaufman
CHM | Chairman | 60 | 2004-12-31 |
Byong Kim
BRD | Director/Board Member | 55 | 2022-02-28 |
Ryan Pruchnic
BRD | Director/Board Member | 53 | 2021-08-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 4/3/25 | Others | Chief Executive Officer | 695,776 | 27.2981% | ||
| 3/13/25 | Others | Chief Executive Officer | 14,386 | 0.5644% | ||
| 3/10/25 | Others | Chief Executive Officer | 28,924 | 1.1348% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -49.38% | 0.00% | -94.78% | -99.81% | 151K | |
| -1.82% | +4.80% | +54.32% | +68.36% | 57.28B | |
| -0.27% | +5.74% | +40.26% | +80.17% | 54.99B | |
| -1.48% | -1.51% | +3.59% | +416.69% | 23.18B | |
| +2.80% | -0.35% | -18.57% | -12.53% | 22.59B | |
| -1.13% | +4.54% | +22.73% | -8.06% | 20.46B | |
| +1.57% | +3.30% | +27.41% | -29.07% | 17.56B | |
| -0.10% | +5.57% | +38.63% | +565.16% | 15.67B | |
| +5.29% | 0.00% | +185.09% | +332.66% | 14.46B | |
| +1.16% | +1.09% | +26.46% | +186.40% | 13.92B | |
| Average | -4.35% | +1.45% | +28.51% | +150.00% | 24.01B | |
| Weighted average by Cap. | +0.01% | +1.93% | +39.92% | +138.62% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 450K 395K 368K 338K 634K 43.12M 643K 4.37M 1.71M 21.29M 1.69M 1.65M 73.59M | 536K 472K 439K 403K 757K 51.44M 767K 5.22M 2.04M 25.4M 2.01M 1.97M 87.79M |
| Net income | -4.62M -4.06M -3.78M -3.47M -6.52M -443M -6.6M -44.93M -17.55M -219M -17.34M -16.97M -756M | -5.02M -4.41M -4.1M -3.77M -7.08M -481M -7.17M -48.79M -19.06M -238M -18.83M -18.42M -821M |
| Net Debt | -3.16M -2.78M -2.58M -2.37M -4.46M -303M -4.51M -30.71M -11.99M -150M -11.85M -11.6M -517M | -2.14M -1.88M -1.75M -1.61M -3.02M -205M -3.06M -20.79M -8.12M -101M -8.02M -7.85M -350M |
Employees
6
| Date | Price | Change | Volume |
|---|
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- LIPO Stock
Select your edition
All financial news and data tailored to specific country editions
